Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Nanovis, a leading developer and provider of nano surface technology that improves the biologic fixation of orthopedic, spine ...

Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...

Nanovis announced today that it sold certain nano surface technology assets and certain IP rights to Medtronic (NYSE:MDT).

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

Medtronic (MDT) reachead $90.01 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. Read more to ...